Back
Avalo Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45
AVTX
Avalo Therapeutics, Inc.
Last Price:
$18.97
Seasonality Move:
0.84%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AVTX is experiencing slight buying pressure.
Avalo Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.75 | Buy |
| 20-day SMA: | 18.49 | Buy |
| 50-day SMA: | 17.3 | Buy |
| 200-day SMA: | 9.74 | Buy |
| 8-day EMA: | 18.85 | Buy |
| 20-day EMA: | 18.41 | Buy |
| 50-day EMA: | 16.93 | Buy |
| 200-day EMA: | 14.07 | Buy |
Avalo Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.58 | Buy |
| Relative Strength Index (14 RSI): | 54.6 | Buy |
| Chaikin Money Flow: | 61837 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.41 - 19.31) | Buy |
| Bollinger Bands (100): | (10.38 - 17.72) | Buy |
Avalo Therapeutics, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Avalo Therapeutics, Inc. Stock
Is Avalo Therapeutics, Inc. Stock a Buy?
-
Avalo Therapeutics, Inc. share price is 18.91 while AVTX 8-day simple moving average is 18.75, which is a Buy signal.
-
The stock price of AVTX is 18.91 while Avalo Therapeutics, Inc. 20-day SMA is 18.49, which makes it a Buy.
-
Avalo Therapeutics, Inc. 50-day simple moving average is 17.30 while AVTX share price is 18.91, making it a Buy technically.
-
AVTX stock price is 18.91 and Avalo Therapeutics, Inc. 200-day simple moving average is 9.74, creating a Buy signal.
AVTX Technical Analysis vs Fundamental Analysis
Sell
45
Avalo Therapeutics, Inc. (AVTX)
is a Sell
Is Avalo Therapeutics, Inc. a Buy or a Sell?
-
Avalo Therapeutics, Inc. stock is rated a SellThe current Avalo Therapeutics, Inc. [AVTX] share price is $18.91. The Score for AVTX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Avalo Therapeutics, Inc. Stock Info
Market Cap:
342.9M
Price in USD:
18.91
Share Volume:
140.7K
Avalo Therapeutics, Inc. 52-Week Range
52-Week High:
20.72
52-Week Low:
3.39
Sell
45
Avalo Therapeutics, Inc. (AVTX)
is a Sell
Avalo Therapeutics, Inc. Share Price Forecast
-
What is the Avalo Therapeutics, Inc. stock price today?The Avalo Therapeutics, Inc. stock price is 18.91 USD today.
-
Will AVTX stock go up or go down?Avalo Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Avalo Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Avalo Therapeutics, Inc. is overvalued.
Is Avalo Therapeutics, Inc. Stock a Buy?
-
Avalo Therapeutics, Inc. share price is 18.91 while AVTX 8-day exponential moving average is 18.85, which is a Buy signal.
-
The stock price of AVTX is 18.91 while Avalo Therapeutics, Inc. 20-day EMA is 18.41, which makes it a Buy.
-
Avalo Therapeutics, Inc. 50-day exponential moving average is 16.93 while AVTX share price is 18.91, making it a Buy technically.
-
AVTX stock price is 18.91 and Avalo Therapeutics, Inc. 200-day simple moving average is 14.07, creating a Buy signal.
Fundamental Analysis of Avalo Therapeutics, Inc.
Is Avalo Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $19.59 per share, and an increase next year of $2.12 per share.
Technical Analysis of Avalo Therapeutics, Inc.
Should I short Avalo Therapeutics, Inc. stock?
-
AVTX Moving Average Covergence Divergence (MACD) indicator is 0.58, suggesting Avalo Therapeutics, Inc. is a Buy
-
Avalo Therapeutics, Inc. Relative Strength Index (RSI) is 54.6, which suggest Avalo Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Avalo Therapeutics, Inc. is (17.41 - 19.31), which suggest Avalo Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Avalo Therapeutics, Inc. is (10.38 - 17.72), which suggest Avalo Therapeutics, Inc. is a Buy
* Avalo Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.